Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Mol Metab. 2021 Nov;53:101309. doi: 10.1016/j.molmet.2021.101309. Epub 2021 Jul 23.
OBJECTIVE: The mechanistic target of rapamycin complex 1 (mTORC1) is dynamically regulated by fasting and feeding cycles in the liver to promote protein and lipid synthesis while suppressing autophagy. However, beyond these functions, the metabolic response of the liver to feeding and insulin signaling orchestrated by mTORC1 remains poorly defined. Here, we determine whether ATF4, a stress responsive transcription factor recently found to be independently regulated by mTORC1 signaling in proliferating cells, is responsive to hepatic mTORC1 signaling to alter hepatocyte metabolism. METHODS: ATF4 protein levels and expression of canonical gene targets were analyzed in the liver following fasting and physiological feeding in the presence or absence of the mTORC1 inhibitor, rapamycin. Primary hepatocytes from wild-type or liver-specific Atf4 knockout (LAtf4) mice were used to characterize the effects of insulin-stimulated mTORC1-ATF4 function on hepatocyte gene expression and metabolism. Both unbiased steady-state metabolomics and stable-isotope tracing methods were employed to define mTORC1 and ATF4-dependent metabolic changes. RNA-sequencing was used to determine global changes in feeding-induced transcripts in the livers of wild-type versus LAtf4 mice. RESULTS: We demonstrate that ATF4 and its metabolic gene targets are stimulated by mTORC1 signaling in the liver, in a hepatocyte-intrinsic manner by insulin in response to feeding. While we demonstrate that de novo purine and pyrimidine synthesis is stimulated by insulin through mTORC1 signaling in primary hepatocytes, this regulation was independent of ATF4. Metabolomics and metabolite tracing studies revealed that insulin-mTORC1-ATF4 signaling stimulates pathways of nonessential amino acid synthesis in primary hepatocytes, including those of alanine, aspartate, methionine, and cysteine, but not serine. CONCLUSIONS: The results demonstrate that ATF4 is a novel metabolic effector of mTORC1 in the liver, extending the molecular consequences of feeding and insulin-induced mTORC1 signaling in this key metabolic tissue to the control of amino acid metabolism.
目的:雷帕霉素复合物 1(mTORC1)的机械靶标在肝脏中通过禁食和进食周期动态调节,以促进蛋白质和脂质合成,同时抑制自噬。然而,除了这些功能之外,mTORC1 协调的肝脏对进食和胰岛素信号的代谢反应仍未得到明确界定。在这里,我们确定了应激反应转录因子 ATF4 是否对肝脏的 mTORC1 信号有反应,以改变肝细胞代谢,ATF4 最近被发现可独立于增殖细胞中的 mTORC1 信号进行调节。
方法:在存在或不存在 mTORC1 抑制剂雷帕霉素的情况下,分析禁食和生理进食后肝脏中 ATF4 蛋白水平和典型基因靶标的表达。使用野生型或肝脏特异性 Atf4 敲除(LAtf4)小鼠的原代肝细胞来表征胰岛素刺激的 mTORC1-ATF4 功能对肝细胞基因表达和代谢的影响。使用无偏稳态代谢组学和稳定同位素示踪方法来定义 mTORC1 和 ATF4 依赖性代谢变化。RNA 测序用于确定野生型与 LAtf4 小鼠肝脏中进食诱导转录物的全局变化。
结果:我们证明 ATF4 及其代谢基因靶标在肝脏中受到 mTORC1 信号的刺激,这种刺激是由胰岛素以肝细胞内在的方式在进食时引起的。虽然我们证明了从头嘌呤和嘧啶合成在原代肝细胞中通过 mTORC1 信号被胰岛素刺激,但这种调节与 ATF4 无关。代谢组学和代谢物示踪研究表明,胰岛素-mTORC1-ATF4 信号刺激了原代肝细胞中非必需氨基酸合成途径,包括丙氨酸、天冬氨酸、蛋氨酸和半胱氨酸,但不包括丝氨酸。
结论:这些结果表明 ATF4 是肝脏中 mTORC1 的新型代谢效应物,将进食和胰岛素诱导的 mTORC1 信号在这种关键代谢组织中的分子后果扩展到氨基酸代谢的控制。
Am J Physiol Gastrointest Liver Physiol. 2025-6-1
Am J Physiol Lung Cell Mol Physiol. 2025-2-1
Am J Physiol Cell Physiol. 2024-7-1
J Appl Physiol (1985). 2025-5-1
J Mol Med (Berl). 2025-6-21
Front Endocrinol (Lausanne). 2024-12-16
Am J Lifestyle Med. 2024-4-9